Our results demonstrate that tRNA interacts with MEK2 and its mutants in pancreatic cancer cells and that the MEK-specific inhibitor U0126 reduces the tRNA-MEK2 interaction in cells. The gene discussed is MAP2K2; the disease is pancreatic neoplasm.